Glycogen storage disease type II - PDFSEARCH.IO - Document Search Engine

Glycogen storage disease type II
Results: 169

#	Item
1	How one patient with a rare disease coped with his genetic disorder Add to Reading List Source URL: www.epp-deutschland.de Language: English - Date: 2015-04-23 11:35:57 Medicine Health Clinical medicine Rare diseases Porphyrias Lysosomal storage diseases RTT Erythropoietic protoporphyria Glycogen storage disease type II Disease
2	LUMIZYME (alglucosidase alfa) for Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-05-26 09:39:24 Clinical medicine Neurochemistry Medicine Sodium channel blockers Alglucosidase alfa Calcium channel blockers Glycogen storage disease type II Ketamine Treprostinil Eptifibatide
3	United States Court of Appeals for the Federal Circuit ______________________ GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP, Add to Reading List Source URL: www.patentchallenges.com Language: English - Date: 2016-08-09 02:08:12 United States patent law BioMarin Pharmaceutical Genzyme Glycogen storage disease type II Inter partes review Pharmaceutical drug Reexamination Patent Trial and Appeal Board Inter partes Iduronidase
4	Pompe disease (Glycogen storage disease type II) Glycogen storage disease type II is also known as acid maltase deficiency or generalized gl Add to Reading List Source URL: www.finnishlapphund-club.co.uk Language: English - Date: 2015-06-20 15:57:04
5	May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im Add to Reading List Source URL: www.apjohnventures.com Language: English - Date: 2014-05-29 15:30:33 Genetic genealogy BioMarin Pharmaceutical Glycogen storage disease type II Acid alpha-glucosidase Lysosomal storage disease Mucopolysaccharidosis Alglucosidase alfa Neuronal ceroid lipofuscinosis Tetrahydrobiopterin Health Rare diseases Medicine
6	Microsoft Word - Apjohn Ventures Fund 2Q10 Letter Final Add to Reading List Source URL: www.apjohnventures.com Language: English BioMarin Pharmaceutical Rare diseases Orphan drugs Lysosomal storage diseases Glycogen storage disease type II Mucopolysaccharidosis Mannose 6-phosphate Hurler syndrome Phenylketonuria Health Medicine Genetic genealogy
7	Alexion to Acquire Synageva to Strengthen Global Leadership in Developing and Commercializing Transformative Therapies for Patients with Devastating and Rare Diseases -- Expands Alexion’s metabolic franchise wi Add to Reading List Source URL: www.alexion-synagevatransaction.com Language: English - Date: 2015-05-06 06:45:36 Alexion Pharmaceuticals Eculizumab Drug discovery Paroxysmal nocturnal hemoglobinuria Clinical trial Glycogen storage disease type II Health Medicine Rare diseases
8	PDF Document Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:22 Lysosomal storage diseases Orphan drugs Glycogen storage disease type II Hepatology Alglucosidase alfa Pharmaceutical Benefits Scheme Amyotrophic lateral sclerosis Clinical trial Health Medicine Rare diseases
9	PDF Document Add to Reading List Source URL: www.hrsa.gov Language: English Glycogen storage disease type II Hepatology Screening Medicine Health Rare diseases
10	Microsoft WordAlglucosidase Genzyme PSD March 2013 FINAL.doc Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:23 Lysosomal storage diseases Glycogen storage disease type II Hepatology Alglucosidase alfa Pharmaceutical Benefits Scheme Amyotrophic lateral sclerosis Clinical trial Health Medicine Rare diseases

UPDATE